Acquired perforating dermatosis associated with sorafenib therapy

J Eur Acad Dermatol Venereol. 2016 Feb;30(2):328-30. doi: 10.1111/jdv.12720. Epub 2014 Sep 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Biopsy
  • Humans
  • Male
  • Middle Aged
  • Niacinamide / administration & dosage
  • Niacinamide / analogs & derivatives*
  • Phenylurea Compounds / administration & dosage*
  • Receptors, Vascular Endothelial Growth Factor
  • Skin / pathology*
  • Skin Diseases / drug therapy*
  • Skin Diseases / pathology
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Niacinamide
  • Sorafenib
  • Receptors, Vascular Endothelial Growth Factor